32 related articles for article (PubMed ID: 17998773)
1. Telmisartan impairs the in vitro osteogenic differentiation of mesenchymal stromal cells from spontaneously hypertensive male rats.
Balera Brito VG; Patrocinio MS; Alves Barreto AE; Tfaile Frasnelli SC; Lara VS; Santos CF; Penha Oliveira SH
Eur J Pharmacol; 2021 Dec; 912():174609. PubMed ID: 34743978
[TBL] [Abstract][Full Text] [Related]
2. Telmisartan ameliorates nephropathy and restores the hippo pathway in rats with metabolic syndrome.
Mohamed B; Ghareib SA; Alsemeh AE; El-Sayed SS
Eur J Pharmacol; 2024 Jun; 973():176605. PubMed ID: 38653362
[TBL] [Abstract][Full Text] [Related]
3. Telmisartan regresses left ventricular hypertrophy in caveolin-1-deficient mice.
Krieger MH; Di Lorenzo A; Teutsch C; Kauser K; Sessa WC
Lab Invest; 2010 Nov; 90(11):1573-81. PubMed ID: 20585312
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen associated to the conservative CKD treatment promoted additional antifibrotic effects on experimental hypertensive nephrosclerosis.
Fanelli C; Francini ALR; Celestrino GA; Teles F; Barbosa AP; Noda P; Iannuzzi LR; Guzzo CR; Ornellas FM; Noronha IL
Sci Rep; 2023 Aug; 13(1):13985. PubMed ID: 37633958
[TBL] [Abstract][Full Text] [Related]
5. Gene expression analysis to identify mechanisms underlying improvement of myocardial fibrosis by finerenone in SHR.
Zhou MS; Zheng SY; Chen C; Li X; Zhang Q; Zhao YJ; Zhang W
Biochem Pharmacol; 2024 Feb; 220():115975. PubMed ID: 38086490
[TBL] [Abstract][Full Text] [Related]
6. Beneficial role of spironolactone, telmisartan and their combination on isoproterenol-induced cardiac hypertrophy.
Goyal BR; Mehta AA
Acta Cardiol; 2012 Apr; 67(2):203-11. PubMed ID: 22641978
[TBL] [Abstract][Full Text] [Related]
7. Topical Spironolactone in the Treatment of Ocular Graft-Versus-Host Disease.
Wong CW; Yang AA; Liu CY; Watsky MA; Lu X; Le HL; Yee RW
Cureus; 2023 Sep; 15(9):e45136. PubMed ID: 37842497
[TBL] [Abstract][Full Text] [Related]
8. Topical Spironolactone in the Treatment of Evaporative Dry Eye Disease.
Wong CW; Wong BS; Ali W; De Jesus ML; Melber TA; Yee RW
Cureus; 2023 Jun; 15(6):e41038. PubMed ID: 37519614
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between peroxisome proliferator-activated receptor-γ and mineralcorticoid receptor in TNF-α activated renal tubular cell.
Xiao J; Chen W; Lu Y; Zhang X; Fu C; Yan Z; Zhang Z; Ye Z
Inflamm Res; 2015 Aug; 64(8):603-14. PubMed ID: 26072064
[TBL] [Abstract][Full Text] [Related]
10. A novel role for SIRT-1 in L-arginine protection against STZ induced myocardial fibrosis in rats.
Rizk SM; El-Maraghy SA; Nassar NN
PLoS One; 2014; 9(12):e114560. PubMed ID: 25501750
[TBL] [Abstract][Full Text] [Related]
11. Effect of angiotensin II receptor blocker on experimental periodontitis in a mouse model of Marfan syndrome.
Suda N; Moriyama K; Ganburged G
Infect Immun; 2013 Jan; 81(1):182-8. PubMed ID: 23115041
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of three angiotensin II type 1 receptor antagonists in preventing liver fibrosis in diabetic rats: stereology, histopathology, and electron microscopy.
Sipal S; Halici Z; Kiki I; Polat B; Albayrak A; Albayrak F; Karakus E; Aksak S; Ozturk B; Gundogdu C
J Mol Histol; 2012 Dec; 43(6):723-35. PubMed ID: 22922994
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N(omega)-nitro-L>-arginine methyl ester/spontaneously hypertensive rats.
Nakamura Y; Ono H; Zhou X; Frohlich ED
Hypertension; 2001 May; 37(5):1262-7. PubMed ID: 11358938
[TBL] [Abstract][Full Text] [Related]
14. Imidapril improves L-NAME-exacerbated nephrosclerosis with TGF-beta 1 inhibition in spontaneously hypertensive rats.
Ono H; Saitoh M; Ono Y; Ishimitu T; Matsuoka H
J Hypertens; 2004 Jul; 22(7):1389-95. PubMed ID: 15201556
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone antagonism ameliorates proteinuria and nephrosclerosis independent of glomerular dynamics in L-NAME/SHR model.
Zhou X; Ono H; Ono Y; Frohlich ED
Am J Nephrol; 2004; 24(2):242-9. PubMed ID: 15031627
[TBL] [Abstract][Full Text] [Related]
16. Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype.
Kim S; Iwao H
J Hypertens Suppl; 1997 Dec; 15(6):S3-7. PubMed ID: 9493120
[TBL] [Abstract][Full Text] [Related]
17. Protective importance of the myogenic response in the renal circulation.
Bidani AK; Griffin KA; Williamson G; Wang X; Loutzenhiser R
Hypertension; 2009 Aug; 54(2):393-8. PubMed ID: 19546375
[No Abstract] [Full Text] [Related]
18. Combination therapy with telmisartan and spironolactone alleviates L-NAME exacerbated nephrosclerosis with an increase in PPAR-gamma and decrease in TGF-beta(1).
Takahashi T; Ono H; Ono Y; Ishimitsu T; Matsuoka H
Int Heart J; 2007 Sep; 48(5):637-47. PubMed ID: 17998773
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
